US biotech Moderna says its vaccine can be repurposed ‘in weeks’ to deal with coronavirus mutations

Open science has been at the heart of the fight-back against the virus. As other crises loom, this underlines the need for governments to avoid protectionist moves and foster collaborative international research

Amid pressure to speed up vaccination programmes some member states are starting to go their own way on securing doses. The EU’s head vaccine official says no country can jump the queue

The pandemic has both spurred on and demonstrated the value of open science, but has also exposed gaps in science policy. Now is a good time for reform, says OECD

As UK looks about to lose its place in virtual European clinical networks, Cambridge University geneticist says ‘this isn’t some nebulous thing’ - a disease might only affect 50 people in the UK, but the top expert may be in Amsterdam

EU4Health aims to boost innovation in the health sector, help member states ditch paper records and make digitised health systems interoperable

Lessons of the pandemic loom large in EU’s pharmaceutical strategy. ‘Never again do we want to see the problems we faced in the first weeks of the crisis,’ says EU vice president Margaritis Schinas

Freedom of information request shows Biomedical Catalyst is backing only 4% of applications assessed as worthy of funding

Strict EU data protection rules are obstructing the sharing of medical data and blocking research